For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Meglumine is a white crystalline powder. Melting point 128-129°C. Soluble in water, slightly soluble in ethanol, almost insoluble in chloroform. Taste sweet and salty astringent. The molecular formula is C7H17NO5 and the molecular weight is 195.21400. The density is 1.375, the melting point is 128-132ºC and the boiling point is 490.4ºC at 760 mmHg.
Meglumine is an amino sugar derived from glucose.
Scope of the Report:
This report focuses on the Meglumine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Meglumine industry is concentrated relatively. For now, there are a few producing companies in the world. The main market players are Merck, Tianma, Qiyuan Plastics and Libang Healthcare Group. The sales of Meglumine increased to 345 MT in 2017 from 315 MT in 2013 with average growth rate of 2.46%.
In consumption market, Europe, USA and China are the mainly consumption regions due to the bigger demand of downstream applications. In 2017, these regions occupied 89.5% of the global consumption volume in total.
Meglumine has two major application, mainly in Cosolvent and Contrast Agent. Meglumine has market potential in the future. Manufacturers engaged in the industry are trying to produce better property Meglumine through improving technology.
The worldwide market for Meglumine is expected to grow at a CAGR of roughly 5.1% over the next five years, will reach 13 million US$ in 2023, from 10 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- Libang Healthcare Group
- New Hualian Pharm
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Diatrizoate Meglumine
- Lothalamate Meglumine
- Lodipamide Meglumine
Market Segment by Applications, can be divided into
There are 15 Chapters to deeply display the global Meglumine market.
Chapter 1, to describe Meglumine Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Meglumine, with sales, revenue, and price of Meglumine, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Meglumine, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Meglumine market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Meglumine sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source